Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma
- PMID: 31576344
- PMCID: PMC6685836
- DOI: 10.21037/atm.2019.06.06
Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.Lancet Oncol. 2019 Apr;20(4):581-590. doi: 10.1016/S1470-2045(18)30907-0. Epub 2019 Feb 28. Lancet Oncol. 2019. PMID: 30827746 Free PMC article.
References
-
- Ciccarese C, Di Nunno V, Montironi R, et al. The role of precision medicine for the treatment of metastatic renal cell carcinoma. Exp Rev Precision Med Drug Development 2016;1:369-77. 10.1080/23808993.2016.1214057 - DOI
Publication types
LinkOut - more resources
Full Text Sources